BDBM536486 3-chloro-5-(1-(2-((3- chloro-6-((S)-2,4- dimethylpiperazin- 1-yl)-2-fluoropyridin- 4-yl)amino)-2-oxo- ethyl)-7-methyl-4- oxo-4,6,7,8-tetra- hydro-1H-dipyrrolo [1,2-a:2',3'-d]pyrimi- din-3-yl)-2-hydroxy- benzamide::US11242351, Compound I-65

SMILES CC1Cc2nc3n(CC(=O)Nc4cc(nc(F)c4Cl)N4CCN(C)C[C@@H]4C)cc(-c4cc(Cl)c(O)c(c4)C(N)=O)c3c(=O)n2C1

InChI Key InChIKey=MWAKEAASVJSTMA-UHFFFAOYSA-N

Data  1 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 536486   

TargetB-cell lymphoma 6 protein [1-129]/Nuclear receptor corepressor 2 [1414-1429](Human)
Ontario Institute For Cancer Research (Oicr)

US Patent
LigandPNGBDBM536486(3-chloro-5-(1-(2-((3- chloro-6-((S)-2,4- dimethylp...)
Affinity DataKd:  6.28nMAssay Description:This assay was used to determine whether compounds inhibit the interaction between the BTB domain of BCL6 and a peptide derived from the BCL6 binding...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/10/2022
Entry Details
Go to US Patent